Produktnummer:
183016d83d018e4e94a1e1acff6cee13fb
| Themengebiete: | Bi-specific constructs Biomarkers Biophysical characterization Cancer Combination therapies Immune-oncology Immune system Monospecific concepts Nanobodies Preclinical studies |
|---|---|
| Veröffentlichungsdatum: | 12.11.2018 |
| EAN: | 9789811304958 |
| Auflage: | 2 |
| Sprache: | Englisch |
| Seitenzahl: | 248 |
| Produktart: | Gebunden |
| Herausgeber: | Bornstein, Gadi G. Klakamp, Scott L. Tabrizi, Mohammad A. |
| Verlag: | Springer Singapore |
| Untertitel: | Translational Considerations & Challenges |
Produktinformationen "Development of Antibody-Based Therapeutics"
With a key focus on recent developments and advances in the field, this book provides in-depth coverage of topics fundamental to the development of targeted therapeutics. The expansion of targeted modalities in rapidly evolving therapeutic areas, such as immune-oncology, and developments with respect to combination therapies, novel technologies, and the therapeutic application of antibody-drug conjugates, are presented. Additionally, the book builds upon topics discussed in the first edition (2012) where recent innovations warrant elaboration. This, the second edition of Development of Antibody-Based Therapeutics: Translational Considerations, represents a comprehensive evaluation of progress in the field, which sits alongside the first edition to inform, in detail, professional and academic researchers, as well as graduate students.
Sie möchten lieber vor Ort einkaufen?
Sie haben Fragen zu diesem oder anderen Produkten oder möchten einfach gerne analog im Laden stöbern? Wir sind gerne für Sie da und beraten Sie auch telefonisch.
Juristische Fachbuchhandlung
Georg Blendl
Parcellistraße 5 (Maxburg)
8033 München
Montag - Freitag: 8:15 -18 Uhr
Samstags geschlossen